Abstract: The purpose of this study is to evaluate the feasibility and acceptability of a TEOSYAL® PureSense Redensity [I] injection using MicronJet® needle in the treatment of crow's feet wrinkles. It is a monocentric, open-blind, prospective, pilot study. 3 injections sessions spaced with an interval of 3 weeks. The last visit will be performed 3 weeks after the last injection. Only, one group of 15 healthy volunteers will be included.
Read full article here: https://www.clinicaltrials.gov/study/NCT02497846?cond=NCT02497846&rank=1
